Document Detail

Cardioprotective actions of wild garlic (allium ursinum) in ischemia and reperfusion.
MedLine Citation:
PMID:  8455576     Owner:  NLM     Status:  MEDLINE    
The susceptibility to ventricular arrhythmias under the conditions of cardiac ischemia and reperfusion was investigated in the Langendorff heart preparation of rats fed for eight weeks a standard chow enriched with 2% of pulverized wild garlic leaves. The isolated hearts were perfused with a modified Krebs-Henseleit solution. The incidence of ventricular fibrillation (VF) during 20 min occlusion of the descending branch of the left coronary artery (LAD) was significantly reduced in the wild garlic group as compared to untreated controls (20% vs 88%). The same holds for the size of the ischemic zone (33.6% vs 40.9% of heart weight). In the reperfusion experiments (5 min after 10 min ischemia), ventricular tachycardia (VT) occurred in 70% of the wild garlic group vs 100% in untreated controls and VF in 50% vs 90%. The time until occurrence of extrasystoles, VT or VR was prolonged. No significant alterations in cardiac fatty acid composition could be observed. Although the prostacyclin production was slightly increased in hearts of the wild garlic group, inhibition of cyclooxygenase by acetylsalicylic acid (ASA; aspirin) could not completely prevent the cardioprotective effects suggesting that the prostaglandin system does not play a decisive role in the cardioprotective action of wild garlic. Furthermore, a moderate angiotensin converting enzyme (ACE) inhibiting action of wild garlic was found in vitro as well as in vivo that could contribute to the cardioprotective and blood pressure lowering action of wild garlic. Whether a free radical scavenging activity of wild garlic is involved in its cardioprotective effects remains to be established.
B Rietz; H Isensee; H Strobach; S Makdessi; R Jacob
Related Documents :
18634916 - Arrhythmogenic right ventricular dysplasia.
10833706 - Infarct related artery patency: relation to serial electropharmacological studies and o...
2321536 - Transmural ventricular activation during consecutive cycles of sustained ventricular ta...
19930106 - Variability in postpacing intervals predicts global ventricular activation pattern duri...
19017516 - Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.
8780206 - Endogenous myocardial norepinephrine is not essential for ischemic preconditioning in r...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Molecular and cellular biochemistry     Volume:  119     ISSN:  0300-8177     ISO Abbreviation:  Mol. Cell. Biochem.     Publication Date:  1993 Feb 
Date Detail:
Created Date:  1993-04-20     Completed Date:  1993-04-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0364456     Medline TA:  Mol Cell Biochem     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  143-50     Citation Subset:  IM    
Physiologisches Institut II, Universität Tübingen/FRG.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin-Converting Enzyme Inhibitors / administration & dosage,  pharmacology*
Arrhythmias, Cardiac / etiology,  prevention & control*
Blood Pressure
Epoprostenol / metabolism
Fatty Acids / analysis
Myocardial Ischemia / prevention & control*
Myocardial Reperfusion
Plant Extracts / administration & dosage,  pharmacology*
Plants, Medicinal*
Rats, Wistar
Ventricular Fibrillation / prevention & control*
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Fatty Acids; 0/Plant Extracts; 35121-78-9/Epoprostenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Release of 6-keto-PGF1 alpha and thromboxane B2 in late appearing cardioprotection induced by the st...
Next Document:  Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models.